ACT-246475 Uses, Dosage, Side Effects and more
ACT-246475 is under investigation in clinical trial NCT03814200 (A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy Subjects).
| Trade Name | ACT-246475 |
| Generic | Selatogrel |
| Selatogrel Other Names | ACT-246475, Selatogrel |
| Type | |
| Formula | C28H39N6O8P |
| Weight | Average: 618.628 Monoisotopic: 618.256699238 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
